Role of the Disulfide Bond in Shiga Toxin A-chain for Toxin Entry into Cells*

(Received for publication, September 17, 1996, and in revised form, January 21, 1997)

Øystein Garred Dagger , Elena Dubinina §, Anna Polesskaya §, Sjur Olsnes Dagger , Juri Kozlov § and Kirsten Sandvig Dagger par

From the Dagger  Institute for Cancer Research at The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway, the § University of Oslo Center for Medical Studies, Moscow, and the W. A. Engelhardt Institute for Molecular Biology, Academy of Sciences of Russia, Vavilov str 32, Russia

ABSTRACT
INTRODUCTION
EXPERMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Shiga toxin consists of an enzymatically active A-chain and a pentameric binding subunit. The A-chain has a trypsin-sensitive region, and upon cleavage two disulfide bonded fragments, A1 and A2, are generated. To study the role of the disulfide bond, it was eliminated by mutating cysteine 242 to serine. In T47D cells this mutated toxin was more toxic than wild type toxin after a short incubation, whereas after longer incubation times wild type toxin was most toxic. Cells cleaved not only wild type but also mutated A-chain into A1 and A2 fragments. The mutated A-chain was more sensitive than wild type toxin to Pronase, and it was degraded at a higher rate in T47D cells. Subcellular fractionation demonstrated transport of both wild type and mutated toxin to the Golgi apparatus. Brefeldin A, which disrupts the Golgi apparatus, protected not only against Shiga toxin but also against the mutated toxin, indicating involvement of the Golgi apparatus. After prebinding of Shiga(C242S) toxin to wells coated with the Shiga toxin receptor, Gb3, trypsin treatment induced dissociation of A1 from the toxin-receptor complex demonstrating that in addition to stabilizing the A-chain, the disulfide bond prevents dissociation of the A1 fragment from the toxin-receptor complex.


INTRODUCTION

Shiga toxin is produced by Shigella dysenteriae type 1 and consists of an enzymatically active A-chain in noncovalent association with a pentamer of B-chains responsible for binding to Gb3, the receptor for Shiga toxin (1-6). After binding, Shiga toxin is endocytosed and transported to the trans-Golgi network (TGN)1 (6, 7). In sensitive cells the toxin is further transported to the endoplasmic reticulum (8-10) where translocation of the A-chain to the cytosol may take place. The A-chain is an N-glycosidase, and after entering the cytosol, it cleaves off a single adenine residue from 28 S rRNA of the 60 S ribosomal subunit, resulting in inhibition of protein synthesis (11, 12).

The A-chain contains two cysteines (Cys-242 and Cys-261) that form a disulfide bond. The resulting loop can be cleaved by trypsin or furin, separating the A-chain into the enzymatically active A1 (27.5 kDa) fragment and the A2 (4.5 kDa) fragment (2, 13, 14). In cells furin was shown to cleave and thereby activate endocytosed Shiga toxin (14). Cleavage and reduction of Shiga toxin A fragment increase the enzymatic activity, indicating that the presence of the A2 fragment has an inhibitory effect on the enzymatic activity of Shiga toxin (13). The crystal structure of Shiga toxin has been resolved at 2.5-Å resolution (15), and interestingly, it shows that the active site in A1 is physically blocked by A2. The possibility existed that A1 and A2 would form a complex and stay together, even without the disulfide bond. To investigate the role of the disulfide bond in the A-chain for intoxication of cells, we have introduced a mutation, C242S, and studied the effect of this A-chain, which does not form a disulfide bond, on different cell lines.

In the present article we demonstrate that the disulfide bond in the A-chain of Shiga toxin is not required for rapid intoxication of cells but seems to be important for toxicity after a long incubation time. The data also suggest that the disulfide bond inhibits dissociation of the A1 fragment from the toxin complex after cleavage and that it inhibits complete degradation of the A-chain both in vitro and in vivo.


EXPERMENTAL PROCEDURES

Materials

Brefeldin A (BFA) was purchased from Epicentre Technologies (Madison, WI). Pronase, trypsin, Hepes, Gb3, N-ethylmaleimide, and PMSF were obtained from Sigma. Na125I was purchased from DuPont (Belgium), and [3H]leucine was purchased from Amersham Int. (Amersham, United Kingdom). Furin was a gift from Dr. Gary Thomas (Vollum Institute, Oregon Health Sciences University, Portland, OR). Shiga toxin was purified as described previously (13) and 125I-labeled as described by Fraker and Speck (16).

Bacteria and Plasmids

Escherichia coli JM109, BMH71-18 mut.S were used for mutagenesis, transformation, recloning into pUC 19, and for isolation of the Shiga toxin. An EcoRI-BamHI restriction fragment if 1.8 kilobase pairs containing ShtA and ShtB was excised from M13 mp8 and subcloned into pALTER (Promega). After mutagenesis, the fragment containing the genes for A and B subunits and the desired mutation in the A subunit was cloned into pUC 19 vector. All bacterial strains were propagated in Luria broth or Luria broth agar, supplemented with antibiotics when necessary. Restriction endonucleases, T4 DNA ligase, and T4 DNA kinase were purchased from New England Biolabs, Inc. (Beverly, MA). Plasmid DNA was purified by methods described by Maniatis et al. (17).

Site-directed Mutagnesis

The point mutation was introduced in the shtA gene by means of the Altered Sites System (Promega). Oligonucleotides designed to introduce mutations were synthesized on the basis of the sequence of the sht as previously published by Kozlov et al. (18). All mutations were confirmed by DNA sequence (19). The oligonucleotides were synthesized on an Applied Biosystem synthesizer and purified with the high pressure liquid chromatography technique. Sequencing primer was 5'-GTAAAACGACGGCCAGT-3'; the mutagenesis primer was 5'-CAACTCGCGATGCATGATGATGAGAATTCAG-3' (C242S).

Cell Culture

HEp-2 cells (from epidermoid carcinoma) were obtained from ATCC (Rockville, MD). HEp-2 cells were grown in Dulbecco's modified Eagle's medium supplemented with 5% serum. T47D cells (from human breast carcinoma) were obtained from the Fibiger Laboratory, Denmark. T47D cells were grown in RPMI medium supplemented with insulin (8 mg/ml) and 10% serum. LoVo cells transfected with mouse furin (LoVo/fur) and control vector (LoVo/neo) were a gift from Dr. E. Mekada (Kurume University, Kurume, Fukuoka, Japan). LoVo cells were grown in Ham's F-12 supplemented with 10% serum. Establishment of these cell lines is described elsewhere (20).

Assay of Shiga Toxin Cytotoxicity

Cells were transferred to 24-wells plates at a density of 3 × 104 cells/well 2 or 3 days prior to the experiments. The cells were incubated with increasing amounts of toxin for the indicated time. Then the cells were incubated for 10 min in Hepes medium with 1 µCi/ml [3H]leucine and no unlabeled leucine. The medium was removed, and the cells were washed 2 times in 5% trichloroacetic acid. Finally the cells were dissolved in 0.1 M KOH, and the radioactivity was measured.

Cleavage of Shiga Toxin by Cultured Cells

Cells were seeded out with a density of 6 × 104 cells/well in 12-well plates 3 days prior to the experiments. The cells were washed in Hepes medium, and then 125I-labeled toxin was added (100 ng/ml) in Hepes medium at 37 °C, and the incubation was continued for the indicated period. In other experiments 125I-labeled toxin was prebound at 0 °C for 20 min, the cells were washed in Hepes medium, and the incubation was continued for the indicated period. Then the cells were washed three times with phosphate-buffered saline and lysed in 1% Triton (1% Triton X-100, 20 mM Hepes, 140 mM NaCl, 1 mM phenylmethanesulfonyl fluoride, pH 7.4) on ice for 20 min. The cell lysate was transferred to Eppendorf tubes, nuclei were removed by centrifugation, and proteins were precipitated for 30 min on ice in the presence of 5% trichloroacetic acid. After centrifugation the pellet was washed in ether, dissolved in sample buffer with or without 6% (v/v) 2-mercaptoethanol, and then subjected to SDS-PAGE.

In Vitro Cleavage of Shiga Toxin and Shiga(C242S) Toxin by Purified Furin

The cleavage was performed in a reaction volume of 25 µl containing 5 mM CaCl2, 1 mM 2-mercaptoethanol, 100 mM buffer (sodium acetate, pH 5.0; MES, pH 5.5-7.5), 10 ng of 125I-Shiga toxin, and 3 ng of purified furin. The reaction mixture was incubated for 3 h at 37 °C, and the reaction was stopped by adding SDS sample buffer with 2-mercaptoethanol. The samples were boiled and subjected to SDS-PAGE.

Trypsin Cleavage of Wild Type Shiga Toxin and Shiga(C242S) Toxin Bound to Gb3

Wells in a 24-well plate were coated with Gb3 at a concentration of 200 µg/ml in 100 µl of Hepes medium for 30 min at 37 °C and then washed 3 times with Hepes medium, before 100 µl of Hepes medium containing 600 ng/ml 125I-labeled toxin was added. The toxin was allowed to bind for 30 min at room temperature, and unbound toxin was removed by washing 3 times with Hepes medium. Then 100 µl of Hepes medium at different pH values (pH 5.5, 6.0, 6.5, 7.0) containing 10 µg/ml trypsin was added to each well and incubated for 2 min at room temperature. The supernatant was transferred to an Eppendorf tube on ice containing a final concentration of 5 mM PMSF and sample buffer; the wells were placed on ice and washed once with Hepes medium, and sample buffer with 2-mercaptoethanol and 5 mM PMSF was added. The wells were scraped with a plastic pipette, and the contents were transferred to Eppendorf tubes. The samples were boiled and subjected to SDS-PAGE and autoradiography.

Trypsin Sensitivity of Wild Type Shiga Toxin and Shiga(C242S) Toxin

125I-Labeled toxin at a concentration of 800 ng/ml in Hepes medium was treated with increasing concentrations of trypsin (0, 0.2, 1, 5, and 10 µg/ml) for 2 min at room temperature. The reaction was stopped by addition of sample buffer containing 2-mercaptoethanol and a final concentration of 5 mM PMSF. The samples were immediately boiled and then subjected to SDS-PAGE and autoradiography.

Pronase Sensitivity of Wild Type Shiga Toxin and Shiga(C242S) Toxin

125I-Labeled toxin at a concentration of 800 ng/ml in a reaction volume of 25 µl of Hepes medium was incubated with increasing concentration of Pronase (0, 1, 3, 10, 30, and 100 µg/ml) for 10 min at room temperature. The reaction was stopped by adding sample buffer containing 2-mercaptoethanol and a final concentration of 5 mM PMSF. The samples were immediately boiled and then subjected to SDS-PAGE and autoradiography.

Acrylamide Gel Electrophoresis

Electrophoresis was carried out as described by Laemmli (21). After electrophoresis the gels were fixed for 30 min in 4% acetic acid and 27% methanol. For autoradiography, Kodak XAR films were exposed to dried gels at -80 °C. After autoradiography, the bands corresponding to A and A1 of Shiga toxin were quantified by densitometry (model 300A, Molecular Dynamics).

Subcellular Fractionation

The cells were fractionated essentially as earlier described (6). Proteins in fractions corresponding to the Golgi zone, load zone, and endosomal/lysosomal zone were precipitated with 5% trichloroacetic acid, dissolved in sample buffer containing 2-mercaptoethanol, and analyzed by SDS-PAGE and autoradiography.


RESULTS

Toxicity of a Mutated Shiga Toxin (C242S) Lacking the Disulfide Bond in the A-chain

Shiga toxin A-chain contains 2 cysteine residues, cysteine 242 and cysteine 261, linked by an internal disulfide bond. The polypeptide loop between the 2 cysteines contains the sequence Arg-Val-Ala-Arg which is recognized and nicked by trypsin or furin (13, 14), thereby separating the A-chain into A1 and A2 fragments. To study the role of the disulfide bond in toxin entry into cells, we constructed a mutated Shiga toxin referred to as Shiga(C242S) toxin where cysteine 242 has been mutated to a serine (Fig. 1). This mutated toxin can no longer form a disulfide bond. To test whether the disulfide bond is required for intoxication of cells, we measured the ability of Shiga(C242S) toxin to intoxicate T47D cells, which are highly sensitive to Shiga toxin. Interestingly, the result showed that Shiga(C242S) toxin was 5-10 times more toxic than wild type toxin when protein synthesis was measured after a 50-min incubation period with toxin continuously present in the medium (Fig. 2A), whereas after 3 h, wild type toxin was 5-10 times more toxic than the mutated toxin (Fig. 2B). After incubation with toxin for 5 h or overnight the difference was almost 100-fold (data not shown). In HEp-2 cells, wild type toxin and Shiga(C242S) toxin were equally toxic after 50 min incubation, whereas after 3 h incubation wild type toxin exhibited a 20-30 times higher toxic activity than the mutated toxin (data not shown). To test whether cleavage by furin was responsible for the comparatively low toxicity of the mutated toxin after long incubation times, we tested the effect of the toxins on LoVo cells, which do not contain functional furin (22). Also in LoVo cells wild type toxin was around 30 times more toxic than the mutated toxin after 3 h incubation with cells, and the difference was 100-fold when cells were exposed to toxins overnight (data not shown).


Fig. 1. Schematic presentation of Shiga toxin with mutation.
[View Larger Version of this Image (11K GIF file)]



Fig. 2. Ability of wild type Shiga toxin and Shiga(C242S) toxin to inhibit protein synthesis in T47D cells. T47D cells were incubated with increasing concentrations of toxins. The ability of the cells to incorporate [3H]leucine was measured after 50 min (A) and 3 h (B) at 37 °C, as described under "Experimental Procedures." bullet , wild type Shiga toxin; black-triangle, Shiga(C242S) toxin.
[View Larger Version of this Image (21K GIF file)]


The lack of increase in toxic effect of the mutated toxin after long incubation times with cells could be due to inactivation of the toxin molecules by serum proteases in the medium. To test this possibility wild type toxin and Shiga(C242S) toxin were incubated in serum-containing medium (without cells) overnight at 37 °C, and then the ability of the toxins to reduce protein synthesis in a short time experiment was measured. The data showed that overnight exposure to medium with serum did not reduce the toxic effect of the mutated molecule (data not shown). To further investigate the reduced toxicity of the mutated toxin after long incubation times with cells, toxin was prebound to the cells at 0 °C, then unbound toxin was washed away, and the incubation was continued for 1.5, 5.5, or 18 h. The cytotoxicity of the wild type toxin increased up to 5 h, whereas the toxic effect of the mutated toxin did not increase after 90 min (Fig. 3). Similar results were also obtained on HEp-2 cells (data not shown). These results suggest that the cells inactivate the mutated toxin more rapidly then the wild type toxin.


Fig. 3. Ability of prebound toxins to inhibit protein synthesis in T47D cells. Increasing concentrations of Shiga toxin and Shiga(C242S) toxin were added to cells that were subsequently kept on ice for 30 min. The cells were washed and then incubated for 1.5, 5.5, or 18 h at 37 °C. The ability of the cells to incorporate [3H]leucine was measured at the end of the incubation, as described under "Experimental Procedures." black-square, wild type toxin, 1.5 h; black-triangle, wild type toxin, 5.5 h; bullet , wild type toxin, 18 h; square , Shiga(C242S) toxin, 1.5 h; triangle , Shiga(C242S) toxin, 5.5 h; open circle , Shiga(C242S) toxin, 18 h.
[View Larger Version of this Image (23K GIF file)]


Proteolytic Processing of the Wild Type Toxin and Shiga(C242S) Toxin

Since Shiga(C242S) toxin was less toxic than wild type toxin after long incubation times with cells (Fig. 3), we tested whether Shiga(C242S) toxin was processed differently than wild type toxin. 125I-Labeled toxin was prebound to T47D cells at 0 °C; then the cells were washed, and the incubation was continued at 37 °C for the indicated period of time and analyzed by SDS-PAGE under nonreducing (Fig. 4) and reducing conditions (data not shown), similar to the experiment in Fig. 3. The result showed that both wild type and mutated Shiga toxin A-chain were processed efficiently to A1 and A2 fragments. Densitometric measurements of the full-length A and A1 bands after a 1-h incubation showed that 55% of the wild type A-chain and 47% of the mutated A-chain was processed to A1 and A2 fragments. The degradation rate of the mutated A-chain (Fig. 4, lanes 6 and 7) was higher than that of wild type toxin A-chain (lanes 3 and 4). Densitometric measurements of the A and A1 bands showed that approximately 70% of the cell-associated mutated A-chain was degraded between 1 and 5 h incubation (lanes 6 and 7). In contrast, there was no significant cellular degradation of wild type A-chain in the same period (lanes 3 and 4).


Fig. 4. Degradation of the A-chain of Shiga(C242S) toxin and wild type Shiga toxin in T47D cells. 125I-Labeled toxins were added to the cells in Hepes medium at 0 °C. After 30 min, the cells were washed, new medium was added, and the cells were incubated for 1 h or 5 h at 37 °C. At the indicated time the cells were washed and lysed in the presence of 5 mM N-ethylmaleimide, and electrophoresis (SDS-PAGE) was carried out under nonreducing condition. Lane 1, molecular mass standards; lanes 2-4, wild type toxin; lanes 5-7, Shiga(C242S) toxin. Lanes 2 and 5 contain wild type toxin and Shiga(C242S) toxin, respectively, which had not been incubated with cells.
[View Larger Version of this Image (34K GIF file)]


The difference in the rates of degradation could be due to different sensitivity of the molecules to proteolytic enzymes and possibly also to different intracellular sorting. We therefore studied the sensitivity of the wild type and the mutated toxin to trypsin and Pronase treatment. Wild type and mutated A-chain were equally sensitive to cleavage by trypsin which under the condition used induced processing to A1 and A2 fragments (Fig. 5). Similarly, processing of the wild type toxin and the mutated toxin to the A1 fragment occurred at the same concentration of Pronase. After treatment with 1 µg/ml Pronase, 20% of the wild type and 22% of the mutated toxin were processed to A1 (Fig. 6, lanes 2 and 8), and after treatment with 3 µg/ml Pronase 53% of wild type and 48% of the mutated toxin were processed (lanes 3 and 9). In contrast, wild type Shiga toxin was more resistant to complete degradation by Pronase than the mutated toxin. In the Pronase sensitivity experiment (Fig. 6), the A and A1 bands were quantified by densitometry. The result showed that the intensity of the A bands of wild type toxin decreased to 55% when the toxin molecules were treated with 100 µg/ml Pronase for 10 min at room temperature. At lower concentrations of Pronase there was no degradation of the wild type A-chain, only processing to form the A1 fragment. In contrast, the intensity of the A bands of the mutated toxin decreased to 64% at 10 µg/ml Pronase. At higher concentrations of Pronase the A and A1 fragments of Shiga(C242S) toxin were almost complete degraded. This shows that Shiga(C242S) toxin is approximately 10 times more sensitive to Pronase treatment than wild type toxin. These results strongly suggest that the disulfide bond protects the A-chain from degradation both in vitro and in vivo.


Fig. 5. Sensitivity of wild type Shiga toxin and Shiga(C242S) toxin to trypsin. 125I-Labeled toxins at concentrations of 800 ng/ml in Hepes medium were treated with increasing concentrations of trypsin for 2 min at room temperature. The reactions were stopped by addition of 5 mM PMSF, and the samples were submitted to 12% SDS-PAGE. Lanes 1-5, wild type Shiga toxin; lanes 6-10, Shiga(C242S) toxin.
[View Larger Version of this Image (26K GIF file)]



Fig. 6. Effect of Pronase treatment on degradation of the A-chain of wild type Shiga toxin and Shiga(C242S) toxin. 125I-Labeled toxin at concentration of 800 ng/ml was incubated for 10 min at room temperature in Hepes medium with increasing concentrations of Pronase. Then sample buffer with 2-mercaptoethanol and 5 mM PMSF was added, and the samples were boiled. The samples were analyzed by SDS-PAGE (12%) and autoradiography. Lanes 1-6, wild type Shiga toxin; lanes 7-12, Shiga(C242S) toxin. In lanes 1 and 7, 125I-labeled toxin that had not been incubated with Pronase is shown.
[View Larger Version of this Image (18K GIF file)]


We have shown earlier that a soluble form of furin cleaves Shiga toxin A-chain with a pH optimum 5.5-6.0, generating A1 and A2 fragments (14). To examine whether Shiga(C242S) toxin was cleaved by furin as efficiently and under the same condition as the wild type toxin, we compared cleavage in vitro at different pH values. As shown in Fig. 7, both wild type toxin and the mutated toxin were cleaved to the same extent with a pH optimum at 5.5.


Fig. 7. Furin-induced cleavage of wild type and Shiga(C242S) toxin in vitro. 125I-Labeled toxins were incubated at 37 °C with a soluble form of furin at different pH values (see "Experimental Procedures"). The reaction products were analyzed by reducing SDS-PAGE (12%) and autoradiography. Lanes 1-7, wild type Shiga toxin; lanes 8-14, Shiga(C242S) toxin. Lanes 1 and 8 contain 125I-labeled wild type and Shiga(C242S) toxin, respectively, that had not been incubated with furin.
[View Larger Version of this Image (50K GIF file)]


Furin appears to cleave endocytosed wild type toxin most likely in the TGN and/or in endosomes (13, 14). We therefore studied the processing of Shiga(C242S) in LoVo cells, both in a stable transfected cell line expressing furin (LoVo/fur) and in a control cell transfected with the vector alone (LoVo/neo). The cells were incubated with 125I-labeled toxin, and toxin processing was then analyzed by SDS-PAGE and autoradiography. In LoVo/fur cells both wild type A-chain and the mutated A-chain were cleaved efficiently into A1 and A2 fragments, and after a 4-h incubation most of the cell-associated toxin molecules were cleaved (Fig. 8b, lanes 3 and 6). In LoVo/neo cells wild type Shiga toxin was cleaved inefficiently, but as shown earlier (14), after long incubation times some cleavage did occur (Fig. 8a, lane 3). Interestingly, there was essentially no processing of Shiga(C242S) toxin (Fig. 8a, lanes 5 and 6).


Fig. 8. Processing of toxins in LoVo/neo (a) and LoVo/fur (b) cells. 125I-Labeled toxins were added to cells in Hepes medium and incubated for 1 or 4 h at 37 °C. After the indicated times the cells were washed and lysed in buffer containing 50 mM Tris, 150 mM NaCl, 1% Triton, and 1 mM PMSF, pH 7.4. Nuclei were removed by centrifugation, and proteins in the supernatant were precipitated by 5% trichloroacetic acid, dissolved in sample buffer containing 6% (v/v) 2-mercaptoethanol, and analyzed by SDS-PAGE (13%). a, LoVo/neo cells, lanes 1-3, wild type Shiga toxin; lanes 4-6, Shiga(C242S) toxin. b, LoVo/fur cells, lanes 1-3, wild type toxin; lanes 4-6, Shiga(C242S) toxin. In both a and b lanes 1 and 4 contain, respectively, wild type toxin and mutated toxins, which had not been added to cells.
[View Larger Version of this Image (22K GIF file)]


To examine the role of the disulfide bond for the integrity of Shiga toxin after cleavage, we used 125I-labeled toxin bound to wells coated with Gb3, the receptor for Shiga toxin. The toxin did not bind to wells not coated with Gb3 (data not shown). After binding, unbound toxin was washed away, and trypsin (10 µg/ml in Hepes medium) was added for 2 min at room temperature to cleave the toxin. Then the supernatant was removed, and SDS sample buffer was added to the well to solubilize the receptor-bound toxin molecules. Proteins both in the supernatant and bound to the plastic were subjected to SDS-PAGE and autoradiography. The experiment was performed at pH 5.5-7.0 to see if pH affected the release of A1 after cleavage. The low pH was used to mimic the low pH in endosomes or TGN. The results showed that upon trypsin treatment the A1 fragment of Shiga(C242S) toxin was released from the toxin-receptor complex after cleavage at all pH values tested (Fig. 9A, lanes 4, 6, 8, and 10). In contrast, when a similar experiment was performed with wild type toxin, the A1 fragment was not released (Fig. 9B, lane 4, 6, 8, and 10). In all cases the B-chains were still attached to the wells with Gb3 (Fig. 9, A and B, lanes 3, 5, 7, and 9). As expected, Shiga(C242S) toxin precleaved with trypsin had reduced cytotoxicity to T47D cells (data not shown).


Fig. 9. Dissociation of A1 fragment from the toxin-receptor complex after cleavage of Shiga(C242S) toxin with trypsin. Wells in a 24-well plate were coated with Gb3 (200 µg/ml) in Hepes medium for 30 min at 37 °C, and then the wells were washed with Hepes medium to remove unbound Gb3, and 125I-labeled toxin (600 ng/ml) in Hepes medium was added at room temperature in the wells and incubated for 30 min. Unbound toxin was washed away with Hepes medium, and 100 µl of Hepes medium with trypsin (10 µg/ml) at pH 5.5, 6.0, 6.5, 7.0 was added per well and incubated for 2 min at room temperature. The supernatant (S) was removed and sample buffer with 2-mercaptoethanol and a final concentration of 5 mM PMSF was added to the supernatant. Proteins still bound to Gb3 on the plastic (P) were solubilized with sample buffer with 5 mM PMSF. Both proteins in the supernatant and bound to Gb3 were analyzed by SDS-PAGE (12%). Lane 1, molecular mass standards; lane 2, 125I-labeled toxin not treated with trypsin; lanes 3, 5, 7, and 9, protein bound to Gb3; lanes 4, 6, 8, and 10, supernatant. A, Shiga(C242S) toxin; B, wild type Shiga toxin.
[View Larger Version of this Image (49K GIF file)]


Intracellular Trafficking of the Toxin Molecules

It has been shown previously that Shiga toxin is transported to the Golgi apparatus (7, 23), and BFA, which disrupts the Golgi apparatus in several cell lines (23-32), protects cells against Shiga toxin (13). This suggests that transport to the Golgi apparatus is required for intoxication. To investigate whether Shiga(C242S) toxin follows the same endocytic pathway to the cytosol, we tested the effect of BFA also on intoxication with this molecule. We found that BFA also protected against Shiga(C242S) toxin (Fig. 10). Furthermore, subcellular fractionation of cells incubated with 125I-labeled toxin showed that approximately 6% of both wild type toxin and Shiga(C242S) toxin were transported to the Golgi apparatus during 1 h (data not shown). Importantly, as shown in Fig. 11, uncleaved Shiga(C242S) toxin A-chain reaches the Golgi apparatus (lane 1).


Fig. 10. Ability of brefeldin A to protect T47D cells against Shiga(C242S) toxin. Cells were incubated with and without brefeldin A (2 µg/ml) in Hepes medium for 20 min at 37 °C. Increasing concentrations of toxin were then added, and the rate of protein synthesis was measured after 1 h, as described under "Experimental Procedures." square , Shiga(C242S) toxin; black-square, Shiga(C242S) toxin and brefeldin A.
[View Larger Version of this Image (16K GIF file)]



Fig. 11. Distribution of uncleaved and cleaved Shiga(C242S) toxin after subcellular fractionation of T47D cells. Cells were incubated with 125I-labeled toxin (100 ng/ml) for 1 h at 37 °C. They were then homogenized and fractionated according to Sandvig et al. (17). Fractions corresponding to the Golgi apparatus, load zone, and endosomes/lysosomes were precipitated with 5% trichloroacetic acid, dissolved in sample buffer containing 6% (v/v) 2-mercaptoethanol, and analyzed by SDS-PAGE (13%) and autoradiography. Lane 1, Golgi zone; lane 2, load zone; lane 3, endosomes and lysosomes.
[View Larger Version of this Image (33K GIF file)]



DISCUSSION

We have introduced a mutation in Shiga toxin A-chain, C242S, to eliminate the disulfide bond in the A-chain, to study the role of the disulfide bond for toxin entry into cells, and for stabilization of the A-chain. Our data show that the disulfide bond is not strictly required for intoxication of cells but is important for efficient intoxication of cells after long incubation times. The results also indicate that the disulfide bond inhibits degradation of the A-chain and inhibits dissociation of the A1 fragment from the toxin-receptor complex after cleavage.

Shiga toxin A-chain is easily cleaved by furin both in vitro and in vivo separating the A-chain into A1 and A2 fragments connected by a disulfide bond (14). In Shiga toxin furin recognizes the sequence Arg-Val-Ala-Arg (14), which is a recognition motif for the membrane-anchored protease furin (33). However, cleavage by furin might also be dependent on protein conformation, and it was not clear whether the enzyme would cleave the mutated molecule under the same conditions as the wild type toxin. As shown here, a soluble form of furin cleaved both the mutated and wild type toxin with the same pH optimum. Furthermore, Shiga(C242S) toxin A-chain was also efficiently cleaved in LoVo cells transfected with furin, whereas in control cells, which do not express functional furin (22), the cleavage was strongly reduced. This demonstrates that furin is able to cleave the mutated toxin also in vivo. Earlier studies have shown that in LoVo cells not transfected with furin (14) wild type toxin is cleaved slowly into A1 and A2 fragments and that an inhibitor of the cytosolic protease calpain both inhibited cleavage and protected LoVo cells against Shiga toxin. Therefore, a protease other than furin, possibly calpain, may cleave and activate Shiga toxin in cells with low furin activity. Calpain has been reported to recognize several different amino acid sequences at the cleavage site, suggesting that other characteristics such as amino acids at a distance from the cleavage site or the protein conformation may be important (34, 35). Thus, the reduced cleavage of the mutated toxin compared with wild type toxin in LoVo cells could be due to lack of recognition of the mutated toxin by calpain.

The disulfide bond in the A-chain of Shiga toxin is not strictly required for intoxication of cells. Interestingly, Shiga (C242S) toxin intoxicated T47D cells more efficiently than wild type toxin after short incubation times. However, after longer incubation times wild type toxin was more toxic than the mutated toxin. These surprising results could be due to different intracellular sorting of the two toxins. However, brefeldin A protected T47D cells not only against wild type toxin (13) but also against the mutated toxin in a short incubation time with cells. Furthermore, subcellular fractionation of cells showed that both wild type and mutated toxin were transported to the Golgi apparatus to the same extent. The results therefore indicate that the pathway used for intoxication of the cells is the same for the two toxins.

Cell-associated Shiga(C242S) toxin clearly intoxicates cells less efficiently than wild type toxin in long incubation times. This is not due to inactivation of Shiga (C242S) toxin by serum proteases in the incubation medium, but seems to be due to cell-mediated inactivation only. In fact, studies in cells showed that the degradation rate of the mutated A-chain was higher than that of the wild type A-chain. Also, the mutated A-chain was more sensitive to Pronase treatment than wild type A-chain. These data suggest that the normal resistance of the wild type toxin to proteases (2) is dependent on the formation of the disulfide bond of the A-chain. Thus, the reduced toxicity of the mutated toxin compared with wild type toxin after long incubation times can be explained by increased cellular degradation of the mutated toxin. We can only speculate on the reason for the strong toxic effect of the mutated toxin on T47D cells after short incubation times. It is possible that the slow reduction rate of the disulfide bond that occurs in the A-chain of the wild type toxin (Ref. 13, also shown in Fig. 4) will delay the action of the toxin sufficiently so that the mutated toxin despite the higher degradation rate can be more toxic than wild type toxin in a short incubation time with cells. This might especially occur in cells like T47D cells where retrograde transport of Shiga toxin to the endoplasmic reticulum may be especially efficient (13).

It appears from the crystal structure of Shiga toxin that the active site cleft in A1 is blocked by a segment of the A2 fragment (15). However, as shown here, possible interactions between the A1 and A2 fragments of Shiga toxin are not sufficiently strong to inhibit the dissociation of the A1 fragment from the toxin-receptor complex of Shiga(C242S) toxin. When the toxin molecule was prebound to a well coated with the receptor for Shiga toxin, cleavage induced rapid dissociation of the A1 fragment from the toxin-receptor complex. In accordance with this, trypsin-nicked mutated toxin was less toxic to T47D cells than unnicked toxin. In contrast to Shiga toxin, the A1 fragment of cholera toxin does not seem to dissociate easily from the toxin complex after reduction of the A-chain (36).

Shiga(C242S) toxin is, similar to the wild type toxin (14), most likely cleaved in the TGN and/or in endosomes, and the A1 fragment may dissociate from the toxin-receptor complex at this location and therefore not intoxicate cells efficiently. Subcellular fractionation of cells showed that uncleaved Shiga(C242S) toxin is able to reach the Golgi apparatus, suggesting that the A-chain can be further transported to the location in the cells where it is translocated to the cytosol, most likely in the endoplasmic reticulum (8-10). Since the mutated toxin is also less toxic than wild type toxin in LoVo cells, which do not process the mutated A-chain into A1 and A2 fragments, the data suggest that increased degradation is more important than furin-induced dissociation of the A1-chain for the decreased ability to intoxicate cells. The data support the view that the disulfide bond has an important role in keeping the A-chain assembled after cleavage and that it protects the A-fragment from degradation.


FOOTNOTES

*   This work was supported by The Norwegian Cancer Society, The Norwegian Research Council for Science and the Humanities, Torsteds legacy, Rachel and Otto Kr. Bruuns legacy, Blix legacy, Odd Fellow, The Jahre Foundation, The Russian Foundation for Basic Research Grant 960449857 and RFBR-INTAS Grant 95-IN/RU-1065.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
par    To whom correspondence should be addressed. Tel.: 47 22934294; Fax: 47 22508692.
1   The abbreviations used are: TGN, trans-Golgi network; PMSF, phenylmethylsulfonyl fluoride; BFA, brefeldin A; MES, 2-(N-morpholino)ethanesulfonic acid; PAGE, polyacrylamide gel electrophoresis.

ACKNOWLEDGEMENTS

We thank Anne-Grethe Myrann and Olga Judkina for expert technical assistance. We also thank Dr. Eisuke Mekada for providing LoVo/neo and LoVo/fur cells and Dr. Gary Thomas for providing purified furin. We are also grateful to Dr. Bjørn Bremnes for critical reading of the manuscript.


REFERENCES

  1. Olsnes, S., and Eiklid, K. (1980) J. Biol. Chem. 255, 284-289 [Abstract/Free Full Text]
  2. Olsnes, S., Reisbig, R., and Eiklid, K. (1981) J. Biol. Chem. 256, 8732-8738 [Abstract/Free Full Text]
  3. Cohen, A., Hannigan, G. E., Williams, B. R. G., and Lingwood, C. A. (1987) J. Biol. Chem. 262, 17088-17091 [Abstract/Free Full Text]
  4. Jacewicz, M., Clausen, H., Nudelman, E., Donohue-Rolfe, A., and Keusch, G. T. (1986) J. Exp. Med. 163, 1391-1404 [Abstract]
  5. Lindberg, A. A., Brown, J. E., Strømberg, N., Westling-Ryd, M., Schultz, J. E., and Karlsson, K. A. (1987) J. Biol. Chem. 262, 1779-1785 [Abstract/Free Full Text]
  6. Sandvig, K., Prydz, K., Ryd, M., and van Deurs, B. (1991) J. Cell Biol. 113, 553-562 [Abstract]
  7. Sandvig, K., Olsnes, S., Brown, J. E., Petersen, O. W., and van Deurs, B. (1989) J. Cell Biol. 108, 1331-1343 [Abstract]
  8. Pelham, H. R. B., Roberts, L. M., and Lord, J. M. (1992) Trends Cell Biol. 2, 183-185 [Medline] [Order article via Infotrieve]
  9. Sandvig, K., Garred, Ø., Prydz, K., Kozlov, J. V., Hansen, S. H., and van Deurs, B. (1992) Nature 358, 510-511 [CrossRef][Medline] [Order article via Infotrieve]
  10. Sandvig, K., Ryd, M., Garred, Ø., Schweda, E., Holm, P. K., and van Deurs, B. (1994) J. Cell Biol. 126, 53-64 [Abstract]
  11. Endo, Y., Tsurugi, K., Yutsudo, T., Takeda, Y., Ogasawara, T., and Igarashi, K. (1988) Eur. J. Biochem. 171, 45-50 [Abstract]
  12. Saxena, S. K., O'Brien, A. D., and Ackerman, E. J. (1989) J. Biol. Chem. 264, 596-601 [Abstract/Free Full Text]
  13. Garred, Ø., Dubinina, E., Holm, P. K., Olsnes, S., van Deurs, B., Kozlov, J. V., and Sandvig, K. (1995) Exp. Cell Res. 218, 39-49 [CrossRef][Medline] [Order article via Infotrieve]
  14. Garred, Ø., van Deurs, B., and Sandvig, K. (1995) J. Biol. Chem. 270, 10817-10821 [Abstract/Free Full Text]
  15. Fraser, M. E., Chernaia, M. M., Kozlov, Y. V., and James, M. N. (1994) Nat. Struct. Biol. 1, 59-64 [Medline] [Order article via Infotrieve]
  16. Fraker, P. J., and Speck, J. C., Jr. (1978) Biochem. Biophys. Res. Commun. 80, 849-857 [Medline] [Order article via Infotrieve]
  17. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1993) in Molecular Cloning: A Laboratory Manual (Ford, N., Nolan, C., and Ferguson, M., eds), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  18. Kozlov, Y. V., Kabishev, A. A., Lukyanov, E. V., and Bayev, A. A. (1988) Gene (Amst.) 67, 213-221 [Medline] [Order article via Infotrieve]
  19. Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J. H., and Roe, B. A. (1980) J. Mol. Biol. 143, 161-178 [Medline] [Order article via Infotrieve]
  20. Komada, M., Hatsuzawa, K., Shibamoto, S., Ito, F., Nakayama, K., and Kitamura, N. (1993) FEBS Lett. 328, 25-29 [CrossRef][Medline] [Order article via Infotrieve]
  21. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  22. Takahashi, S., Kasai, K., Hatsuzawa, K., Kitamura, N., Misumi, Y., Ikehara, Y., Murakami, K., and Nakayama, K. (1993) Biochem. Biophys. Res. Commun. 195, 1019-1026 [CrossRef][Medline] [Order article via Infotrieve]
  23. Sandvig, K., Prydz, K., Hansen, S. H., and van Deurs, B. (1991) J. Cell Biol. 115, 971-981 [Abstract]
  24. Damke, H., Klumperman, J., von Figura, K., and Braulke, T. (1991) J. Biol. Chem. 266, 24829-24833 [Abstract/Free Full Text]
  25. Doms, R. W., Russ, G., and Yewdell, J. W. (1989) J. Cell Biol. 109, 61-72 [Abstract]
  26. Fujiwara, T., Oda, K., and Ikehara, Y. (1989) Cell Struct. Funct. 14, 605-616 [Medline] [Order article via Infotrieve]
  27. Fujiwara, T., Oda, K., Yokota, S., Takatsuki, A., and Ikehara, Y. (1988) J. Biol. Chem. 263, 18545-18552 [Abstract/Free Full Text]
  28. Lippincott-Schwartz, J., Donaldson, J. G., Schweizer, A., Berger, E. G., Hauri, H.-P., Yuan, L. C., and Klausner, R. D. (1990) Cell 60, 821-836 [Medline] [Order article via Infotrieve]
  29. Lippincott-Schwartz, J., Yuan, L., Tipper, C., Amherdt, M., Orci, L., and Klausner, R. D. (1991) Cell 67, 601-616 [Medline] [Order article via Infotrieve]
  30. Misumi, Y., Misumi, Y., Miki, K., Takatsuki, A., Tamura, G., and Ikehara, Y. (1986) J. Biol. Chem. 261, 11398-11403 [Abstract/Free Full Text]
  31. Shite, S., Seguchi, T., Mizoguchi, H., Ono, M., and Kuwano, M. (1990) J. Biol. Chem. 265, 17385-17388 [Abstract/Free Full Text]
  32. Ulmer, J. B., and Palade, G. E. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 6992-6996 [Abstract]
  33. Molloy, S. S., Bresnahan, P. A., Leppla, S. H., Klimpel, K. R., and Thomas, G. (1992) J. Biol. Chem. 267, 16396-16402 [Abstract/Free Full Text]
  34. Croall, D. E., and DeMartino, G. N. (1991) Physiol. Rev. 71, 813-847 [Free Full Text]
  35. David, L. L., Shearer, T. R., and Shih, M. (1993) J. Biol. Chem. 268, 1937-1940 [Abstract/Free Full Text]
  36. Mekalanos, J. J., Collier, R. J., and Romig, W. R. (1979) J. Biol. Chem. 254, 5855-5861 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.